Hopes rise over experimental drug's effectiveness against coronavirus
by Hannah Devlin and Ian Sample from Science | The Guardian on (#50G5F)
Many see remdesivir as one of few drugs that has reasonable prospect of helping patients
A US biotech firm has ramped up production of an experimental drug that has become a focal point for hopes of an effective treatment for coronavirus.
The first clinical trial of the antiviral medicine remdesivir in Covid-19 patients is due to report its findings next month according to Gilead Sciences, which said it had accelerated manufacturing of the drug to increase its supplies "as rapidly as possible".
Continue reading...